Metronomic chemoimmunotherapy in a patient with refractory Waldenstrom's macroglobulinemia.
Fassas
Athanasios B-T
AB
Kiwan
Elias
E
Roberts
Jennifer
J
Burr
Tammy
T
Tricot
Guido
G
Anaissie
Elias
E
Barlogie
Bart
B
D000368:Aged; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D016879:Salvage Therapy / Q000379:methods; D016896:Treatment Outcome; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D007155:Immunologic Factors; D000074323:Alemtuzumab